Shirin Kalimuddin October M Sessions Yan'An Hou Eng Eong Ooi David Sim Sivathasan Cumaraswamy Teing Ee Tan Siang Hui Lai Chian Yong Low
10.1016/j.jcv.2012.10.005
J Clin Virol
2013 Jan;56(1):37-40.
NO-CC CODE
https://pubmed.ncbi.nlm.nih.gov/23137789/
Antiviral Agents / administration & dosage Immunoglobulins, Intravenous / administration & dosage Myocarditis / drug therapy Parainfluenza Virus 2, Human / isolation & purification Ribavirin / administration & dosage Rubulavirus Infections / complications Rubulavirus Infections / drug therapy
Antiviral Agents / administration & dosage Immunoglobulins, Intravenous / administration & dosage Myocarditis / drug therapy Parainfluenza Virus 2, Human / isolation & purification Ribavirin / administration & dosage Rubulavirus Infections / complications Rubulavirus Infections / drug therapy Case Reports Administration, Intravenous Humans Male Middle Aged Molecular Sequence Data Myocarditis / virology RNA, Viral / genetics Rubulavirus Infections / virology Sequence Analysis, DNA Treatment Outcome Antiviral Agents Immunoglobulins, Intravenous RNA, Viral Ribavirin
PMC7185820
23137789
Successful clearance of human parainfluenza virus type 2 viraemia with intravenous ribavirin and immunoglobulin in a patient with acute myocarditis
2013